Interesting summary of #morpheusliver #HCC data and issues. #tigit inh. #tiragolumab + #tecentriq #avastin performed well vs. #IMBRAVE150 doublet but latter underperformed. PFS unprecedented. Exciting but await #IMBRAVE152 to confirm #livertwitter...
1
0
1
0